Atlas Trials

Neurocognitive Decline in Patients With Brain Metastases

Clinical trial NCT03508752 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03508752
Sponsor
University of Texas Southwestern Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Brain Metastases
Start date
2017-12-05
Primary completion
2026-06-20
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.